UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

The American journal of pathology, 2016-03, Vol.186 (3), p.652-658

2016

Volltextzugriff (PDF)

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Emerging infectious diseases, 2016-10, Vol.22 (10), p.1824-1826

2016

Volltextzugriff (PDF)

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children

The New England journal of medicine, 2015-02, Vol.372 (9), p.835-845

2015

Volltextzugriff (PDF)

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

Clinical infectious diseases, 2014-11, Vol.59 (9), p.1225-1233

2014

Volltextzugriff (PDF)

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease

PloS one, 2013-09, Vol.8 (9), p.e74905

2013

Volltextzugriff (PDF)

Progress and Challenges in RSV Prophylaxis and Vaccine Development

The Journal of infectious diseases, 2013-12, Vol.208 (suppl 3), p.S177-S183

Haynes, Lia M.

2013

Volltextzugriff (PDF)

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi

Emerging infectious diseases, 2016-04, Vol.22 (4), p.647-656

2016

Volltextzugriff (PDF)

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

Antiviral research, 2018-06, Vol.154, p.149-157

2018

Volltextzugriff (PDF)

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

The Journal of infectious diseases, 2009-08, Vol.200 (3), p.439-447

2009

Volltextzugriff (PDF)

Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

Journal of Virology, 2009-02, Vol.83 (3), p.1492-1500

2009

Volltextzugriff (PDF)

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel

Emerging infectious diseases, 2016-11, Vol.22 (11), p.1915-1920

2016

Volltextzugriff (PDF)

The prevalence of Middle East respiratory syndrome coronavirus (MERS‐CoV) antibodies in dromedary camels in Israel

Zoonoses and public health, 2018-09, Vol.65 (6), p.749-754

2018

Volltextzugriff (PDF)

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice

PloS one, 2012-12, Vol.7 (12), p.e51485-e51485

2012

Volltextzugriff (PDF)

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014

Emerging infectious diseases, 2016-08, Vol.22 (8), p.1395-1402

2016

Volltextzugriff (PDF)

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells

BMC research notes, 2016-01, Vol.9 (10), p.11-11, Article 11

2016

Volltextzugriff (PDF)

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

Journal of Virology, 2013-10, Vol.87 (20), p.10955-10967

2013

Volltextzugriff (PDF)

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice

Virology (New York, N.Y.), 2015-09, Vol.483, p.117-125

2015

Volltextzugriff (PDF)

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security

Emerging infectious diseases, 2017-12, Vol.23 (13), p.S121-S125

2017

Volltextzugriff (PDF)

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Nature immunology, 2000-11, Vol.1 (5), p.398-401

2000

Volltextzugriff (PDF)

Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus

The Journal of infectious diseases, 2014-06, Vol.209 (12), p.1870-1872

2014

Volltextzugriff (PDF)

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice

PloS one, 2013-12, Vol.8 (12), p.e83075-e83075

2013

Volltextzugriff (PDF)

RSV Growth and Quantification by Microtitration and qRT-PCR Assays

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1442, p.13

2016

Volltextzugriff (PDF)

Health care worker contact with MERS patient, Saudi Arabia

Emerging infectious diseases, 2014-12, Vol.20 (12), p.2148-2151

2014

Volltextzugriff (PDF)

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Journal of Virology, 2010-09, Vol.84 (18), p.9632-9636

2010

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(86)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(49)
Animals
(33)
Humans
(33)
Female
(30)
Immunology
(25)
Infectious Diseases
(23)
Mice
(23)
Respiratory Syncytial Virus
(20)
Male
(19)
Virology
(17)
Mice, Inbred Balb C
(16)
Microbiology
(16)
Biological And Medical Sciences
(15)
Viruses
(15)
Adult
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Coronavirus Infections - Epidemiology
(13)
Health Aspects
(13)
Infections
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease

Progress and Challenges in RSV Prophylaxis and Vaccine Development

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel

The prevalence of Middle East respiratory syndrome coronavirus (MERS‐CoV) antibodies in dromedary camels in Israel

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice

RSV Growth and Quantification by Microtitration and qRT-PCR Assays

Health care worker contact with MERS patient, Saudi Arabia

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Suchergebnisse filtern